 |
PDBsum entry 3k2u
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Hydrolase/immune system
|
PDB id
|
|
|
|
3k2u
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
233 a.a.
|
 |
|
|
|
|
|
|
|
215 a.a.
|
 |
|
|
|
|
|
|
|
208 a.a.
|
 |
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Hydrolase/immune system
|
 |
|
Title:
|
 |
Crystal structure of hgfa in complex with the allosteric inhibitory antibody fab40
|
|
Structure:
|
 |
Hepatocyte growth factor activator long chain. Chain: a. Synonym: hgf activator, hgfa. Engineered: yes. Hepatocyte growth factor activator short chain. Chain: b. Synonym: hgf activator, hgfa. Engineered: yes. Antibody, fab fragment, heavy chain.
|
|
Source:
|
 |
Homo sapiens. Human. Organism_taxid: 9606. Expressed in: trichoplusia ni. Expression_system_taxid: 7111. Expressed in: escherichia coli. Expression_system_taxid: 562.
|
|
Resolution:
|
 |
|
2.35Å
|
R-factor:
|
0.239
|
R-free:
|
0.290
|
|
|
Authors:
|
 |
R.Ganesan,C.Eigenbrot,S.Shia
|
|
Key ref:
|
 |
R.Ganesan
et al.
(2009).
Unraveling the allosteric mechanism of serine protease inhibition by an antibody.
Structure,
17,
1614-1624.
PubMed id:
|
 |
|
Date:
|
 |
|
30-Sep-09
|
Release date:
|
15-Dec-09
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
Q04756
(HGFA_HUMAN) -
Hepatocyte growth factor activator from Homo sapiens
|
|
|
|
Seq: Struc:
|
 |
 |
 |
655 a.a.
233 a.a.
|
|
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
Structure
17:1614-1624
(2009)
|
|
PubMed id:
|
|
|
|
|
| |
|
Unraveling the allosteric mechanism of serine protease inhibition by an antibody.
|
|
R.Ganesan,
C.Eigenbrot,
Y.Wu,
W.C.Liang,
S.Shia,
M.T.Lipari,
D.Kirchhofer.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Recent structural studies have outlined the mechanism of protease inhibition by
active site-directed antibodies. However, the molecular basis of allosteric
inhibition by antibodies has been elusive. Here we report the 2.35 A resolution
structure of the trypsin-like serine protease hepatocyte growth factor activator
(HGFA) in complex with the allosteric antibody Ab40, a potent inhibitor of HGFA
catalytic activity. The antibody binds at the periphery of the substrate binding
cleft and imposes a conformational change on the entire 99-loop
(chymotrypsinogen numbering). The altered conformation of the 99-loop is
incompatible with substrate binding due to the partial collapse of subsite S2
and the reorganization of subsite S4. Remarkably, a single residue deletion of
Ab40 abolished inhibition of HGFA activity, commensurate with the reversal of
the 99-loop conformation to its "competent" state. The results define an
"allosteric switch" mechanism as the basis of protease inhibition by an
allosteric antibody.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
');
}
}
 |
| |